A Multi-institutional Phase I and Biomarker Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Everolimus (Primary) ; Bicalutamide; Leuprorelin
- Indications Prostate cancer
- Focus Adverse reactions
- 30 Apr 2014 According to the ClinicalTrials.gov record, status changed from recruiting to withdrawn prior to recruitment.
- 01 Oct 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Jul 2012 New trial record